146,745 Shares in Ralliant Corporation $RAL Bought by Man Group plc

Man Group plc bought a new position in shares of Ralliant Corporation (NYSE:RAL) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 146,745 shares of the company’s stock, valued at approximately $10,805,000. Man Group plc owned approximately 0.13% of Ralliant at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Dunhill Financial LLC acquired a new stake in shares of Ralliant during the second quarter worth about $25,000. Global Retirement Partners LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at approximately $35,000. Group One Trading LLC acquired a new position in shares of Ralliant in the 2nd quarter valued at approximately $36,000. Danske Bank A S bought a new stake in Ralliant during the 4th quarter worth approximately $25,000. Finally, Persistent Asset Partners Ltd bought a new stake in Ralliant during the 2nd quarter worth approximately $37,000.

Insider Activity

In other Ralliant news, CEO Tamara S. Newcombe sold 12,936 shares of the company’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $71.79, for a total value of $928,675.44. Following the sale, the chief executive officer owned 251,967 shares in the company, valued at $18,088,710.93. This represents a 4.88% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Karen M. Bick sold 6,062 shares of the firm’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $72.00, for a total value of $436,464.00. Following the completion of the sale, the senior vice president directly owned 31,668 shares of the company’s stock, valued at approximately $2,280,096. The trade was a 16.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Company insiders own 0.42% of the company’s stock.

Ralliant Price Performance

Shares of RAL opened at $61.65 on Friday. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.75. The company’s fifty day simple moving average is $68.40 and its 200 day simple moving average is $56.42. Ralliant Corporation has a 1-year low of $37.27 and a 1-year high of $75.41. The company has a market cap of $6.82 billion, a price-to-earnings ratio of -5.68, a PEG ratio of 2.35 and a beta of 1.60.

Ralliant (NYSE:RAL) last announced its quarterly earnings results on Thursday, July 30th. The company reported $0.68 EPS for the quarter, beating analysts’ consensus estimates of $0.63 by $0.05. Ralliant had a negative net margin of 56.38% and a positive return on equity of 14.97%. The firm had revenue of $567.80 million during the quarter. Ralliant has set its FY 2026 guidance at 2.760-2.900 EPS and its Q3 2026 guidance at 0.720-0.780 EPS. On average, research analysts forecast that Ralliant Corporation will post 2.87 earnings per share for the current fiscal year.

Ralliant Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 23rd. Investors of record on Tuesday, September 8th will be paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.3%. The ex-dividend date is Tuesday, September 8th. Ralliant’s dividend payout ratio (DPR) is -1.84%.

Analyst Upgrades and Downgrades

RAL has been the topic of a number of research reports. Oppenheimer lifted their price target on shares of Ralliant from $50.00 to $65.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Evercore initiated coverage on shares of Ralliant in a research report on Tuesday, June 9th. They set an “outperform” rating and a $80.00 price objective for the company. Truist Financial restated a “buy” rating and set a $82.00 price objective (up from $68.00) on shares of Ralliant in a report on Friday, July 31st. Wall Street Zen raised shares of Ralliant from a “buy” rating to a “strong-buy” rating in a research report on Saturday, August 22nd. Finally, Zacks Research raised shares of Ralliant from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, June 30th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Ralliant currently has an average rating of “Moderate Buy” and an average price target of $75.70.

About Ralliant

Ralliant, Inc (NYSE: RAL) is a medical technology company focused on enabling point-of-care cell therapy solutions in the field of regenerative medicine. The company develops and markets systems that isolate, concentrate and store adipose-derived stromal vascular fraction (SVF) cells directly from a patient’s own fat tissue, facilitating same-day, autologous treatments without the need for extensive laboratory infrastructure.

The company’s core product portfolio includes proprietary device platforms and single-use processing kits engineered to streamline the workflow for clinicians.